journal
MENU ▼
Read by QxMD icon Read
search

Cancer

journal
https://read.qxmd.com/read/31299106/outcomes-for-older-adults-with-acute-myeloid-leukemia-after-an-intensive-care-unit-admission
#1
Samuel D Slavin, Alyssa Fenech, Amanda L Jankowski, Gregory A Abel, Andrew M Brunner, David P Steensma, Amir T Fathi, Daniel J DeAngelo, Martha Wadleigh, Gabriela S Hobbs, Philip C Amrein, Richard M Stone, Jennifer S Temel, Areej El-Jawahri
BACKGROUND: Older adults with acute myeloid leukemia (AML) are often assumed to have poor outcomes after admission to the intensive care unit (ICU). However, little is known about ICU utilization and post-ICU outcomes in this population. METHODS: The authors conducted a retrospective analysis for 330 patients who were 60 years old or older and were diagnosed with AML between 2005 and 2013 at 2 hospitals in Boston.They used descriptive statistics to examine the proportion of patients admitted to the ICU as well as their mortality and functional recovery...
July 12, 2019: Cancer
https://read.qxmd.com/read/31299092/management-and-outcomes-among-patients-with-sarcomatoid-hepatocellular-carcinoma-a-population-based-analysis
#2
Lu Wu, Diamantis I Tsilimigras, Ayesha Farooq, J Madison Hyer, Katiuscha Merath, Anghela Z Paredes, Rittal Mehta, Kota Sahara, Feng Shen, Timothy M Pawlik
BACKGROUND: Few data are available regarding the management and outcomes among patients with sarcomatoid hepatocellular carcinoma (HCC) due to its rarity. METHODS: Patients diagnosed with sarcomatoid HCC from 2004 through 2015 were identified in the National Cancer Data Base. Overall survival (OS) was calculated among patients with sarcomatoid versus conventional HCC using a 1:3 propensity score matching based on sex, age, and American Joint Committee on Cancer (AJCC) stage of disease...
July 12, 2019: Cancer
https://read.qxmd.com/read/31299091/using-qualitative-research-to-reduce-readmissions-and-optimize-perioperative-cystectomy-care
#3
Angela B Smith, Dana Mueller, Brandon Garren, Hung-Jui Tan, Eric Wallen, Michael Woods, Raj Pruthi, Matthew Nielsen
BACKGROUND: Preventable complications and readmissions after cystectomy may be detectable via postoperative monitoring of patient-reported outcomes (PROs). However, no study has defined meaningful PROs or the use of mobile communication devices (mobile health [mHealth]) to capture them. The objectives of this study were to determine which high-priority PROs influence patients' perioperative experience, what processes influence these outcomes, how patients and caregivers differ in their experiences, and how mHealth might be used to improve outcomes...
July 12, 2019: Cancer
https://read.qxmd.com/read/31299089/effect-of-fragmentation-of-cancer-care-on-treatment-use-and-survival-in-hepatocellular-carcinoma
#4
Caitlin A Hester, Nishika Karbhari, Nicole E Rich, Mathew Augustine, John C Mansour, Patricio M Polanco, Matthew R Porembka, Sam C Wang, Herbert J Zeh, Amit G Singal, Adam C Yopp
BACKGROUND: Fragmented cancer care (FC), or care received from multiple institutions, increases systemic health care costs and potentiates cancer care disparities. There is a paucity of data on mechanisms contributing to FC and the resulting effect on patient outcomes. This study characterized patient- and hospital-level factors associated with FC, time to treatment (TTT), and overall survival (OS) in patients with hepatocellular carcinoma (HCC). METHODS: Patients newly diagnosed with HCC from 2004 to 2015 and receiving treatment were identified in the Texas Cancer Registry...
July 12, 2019: Cancer
https://read.qxmd.com/read/31299088/optimizing-cystectomy-outcomes
#5
EDITORIAL
Sima P Porten, Viraj A Master
No abstract text is available yet for this article.
July 12, 2019: Cancer
https://read.qxmd.com/read/31299086/addressing-fragmentation-of-care-requires-strengthening-of-health-systems-and-cross-institutional-collaboration
#6
EDITORIAL
George Molina, Motaz Qadan
No abstract text is available yet for this article.
July 12, 2019: Cancer
https://read.qxmd.com/read/31291014/racial-and-ethnic-disparities-in-neurocognitive-emotional-and-quality-of-life-outcomes-in-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer-survivor-study
#7
Stephanie B Dixon, Nan Li, Yutaka Yasui, Smita Bhatia, Jacqueline N Casillas, Todd M Gibson, Kirsten K Ness, Jerlym S Porter, Rebecca M Howell, Wendy M Leisenring, Leslie L Robison, Melissa M Hudson, Kevin R Krull, Gregory T Armstrong
BACKGROUND: Survivors of childhood cancer are at risk of neurocognitive impairment, emotional distress, and poor health-related quality of life (HRQOL); however, the effect of race/ethnicity is understudied. The objective of this study was to identify race/ethnicity-based disparities in neurocognitive, emotional, and HRQOL outcomes among survivors of childhood cancer. METHODS: Self-reported measures of neurocognitive function, emotional distress (the Brief Symptom Inventory-18), and HRQOL (the Medical Outcomes Study Short Form-36 health survey) were compared between minority (Hispanic, n = 821; non-Hispanic black [NHB], n = 600) and non-Hispanic white (NHW) (n = 12,287) survivors from the Childhood Cancer Survivor Study (median age, 30...
July 10, 2019: Cancer
https://read.qxmd.com/read/31291012/current-treatment-strategies-for-measurable-residual-disease-in-patients-with-acute-myeloid-leukemia
#8
REVIEW
Mary-Elizabeth M Percival, Elihu H Estey
Patients with acute myeloid leukemia (AML) who achieve a morphologic complete remission still can have measurable residual disease (MRD) detected by multiparametric flow cytometry, molecular methods, or cytogenetics. Such patients with MRD have a high risk of disease recurrence over a short timeframe, but optimal treatment strategies are unknown. Outcomes with conventional treatment, including allogeneic hematopoietic cell transplantation, are worse than those for patients without MRD. Herein, the authors review current strategies, including novel clinical trials, targeted toward patients with MRD...
July 10, 2019: Cancer
https://read.qxmd.com/read/31291011/practices-and-perceptions-regarding-intravenous-opioid-infusion-and-cancer-pain-management
#9
Joseph A Arthur, Akhila Reddy, Uniqua Smith, David Hui, Minjeong Park, Diane Liu, Nicole Vaughan-Adams, Ali Haider, Janet Williams, Eduardo Bruera
BACKGROUND: In view of the recent opioid crisis, ways to promote safe and effective opioid-related practices are needed. Faster intravenous (iv) opioid infusion rates can result in increased adverse effects and risk for nonmedical opioid use. Data on best practices regarding safe iv opioid administration for cancer pain are limited. This study examined iv opioid bolus infusion practices and perceptions about opioids in cancer pain among 4 groups of inpatient oncology nurses. METHODS: An anonymous cross-sectional survey was conducted among oncology nurses working in medical, surgical, intensive care unit (ICU), and emergency department (ED) settings...
July 10, 2019: Cancer
https://read.qxmd.com/read/31291010/intent-and-subsequent-initiation-of-human-papillomavirus-vaccine-among-young-cancer-survivors
#10
Brooke Cherven, Sharon M Castellino, Yanjun Chen, F Lennie Wong, Jocelyn M York, Karen Wasilewski-Masker, Melissa M Hudson, Smita Bhatia, James L Klosky, Wendy Landier
BACKGROUND: Despite an increased risk of subsequent human papillomavirus (HPV)-related malignancies, HPV vaccine initiation rates among cancer survivors remain critically low. The purpose of this study was to determine the relationship between HPV vaccine intent and subsequent vaccine initiation among cancer survivors by linking data from a cross-sectional survey with state-based immunization registry records. METHODS: Cancer survivors who were 9 to 26 years old were surveyed 1 to 5 years after their treatment to assess their HPV vaccine initiation status, HPV vaccine intent, sociodemographic factors, and vaccine-related health beliefs...
July 10, 2019: Cancer
https://read.qxmd.com/read/31291006/reply-to-deprescription-during-last-year-of-life-in-patients-with-pancreatic-cancer-optimization-or-nihilism
#11
LETTER
Lucas Morin, Stephen Barclay, Jonas W Wastesson, Kristina Johnell, Adam Todd
No abstract text is available yet for this article.
July 10, 2019: Cancer
https://read.qxmd.com/read/31291004/reply-to-mini-hcvd-plus-inotuzumab-plus-or-minus-blinatumomab-hype-or-hope
#12
LETTER
Koji Sasaki, Hagop M Kantarjian, Elias J Jabbour
No abstract text is available yet for this article.
July 10, 2019: Cancer
https://read.qxmd.com/read/31291001/mini-hcvd-plus-inotuzumab-plus-or-minus-blinatumomab-hype-or-hope
#13
LETTER
Bernard L Marini, Anthony J Perissinotti, Dale L Bixby, Patrick W Burke, Kristen M Pettit, Lydia L Benitez
No abstract text is available yet for this article.
July 10, 2019: Cancer
https://read.qxmd.com/read/31290998/deprescription-during-last-year-of-life-in-patients-with-pancreatic-cancer-optimization-or-nihilism
#14
LETTER
Gabriele Capurso
No abstract text is available yet for this article.
July 10, 2019: Cancer
https://read.qxmd.com/read/31290997/immune-checkpoint-inhibitors-for-hepatocellular-carcinoma
#15
REVIEW
Imane El Dika, Danny N Khalil, Ghassan K Abou-Alfa
The position of immunotherapy as a pillar of systemic cancer treatment has been firmly established over the past decade. Immune checkpoint inhibitors are a welcome option for patients with different malignancies. This is in part because they offer the possibility of durable benefit, even for patients who have failed other treatment modalities. The recent demonstration that immunotherapy is effective for patients with hepatocellular carcinoma (HCC) is a milestone in the history of this recalcitrant disease. The treatment of HCC has been a challenge, and for many years was limited to the tyrosine kinase inhibitor sorafenib and to several novel tyrosine kinase inhibitors that have shown efficacy and have been approved...
July 10, 2019: Cancer
https://read.qxmd.com/read/31290996/a-phase-1-and-randomized-placebo-controlled-phase-2-trial-of-bevacizumab-plus-dasatinib-in-patients-with-recurrent-glioblastoma-alliance-north-central-cancer-treatment-group-n0872
#16
Evanthia Galanis, S Keith Anderson, Erin L Twohy, Xiomara W Carrero, Jesse G Dixon, David Dinh Tran, Suriya A Jeyapalan, Daniel M Anderson, Timothy J Kaufmann, Ryan W Feathers, Caterina Giannini, Jan C Buckner, Panos Z Anastasiadis, David Schiff
BACKGROUND: Src signaling is markedly upregulated in patients with invasive glioblastoma (GBM) after the administration of bevacizumab. The Src family kinase inhibitor dasatinib has been found to effectively block bevacizumab-induced glioma invasion in preclinical models, which led to the hypothesis that combining bevacizumab with dasatinib could increase bevacizumab efficacy in patients with recurrent GBM. METHODS: After the completion of the phase 1 component, the phase 2 trial (ClinicalTrials...
July 10, 2019: Cancer
https://read.qxmd.com/read/31290995/colon-cancer-as-a-subsequent-malignant-neoplasm-in-young-adults
#17
Annabelle Teng, Daniel W Nelson, Ahmed Dehal, Shu-Ching Chang, Trevan Fischer, Scott R Steele, Melanie Goldfarb
BACKGROUND: The incidence of colon cancer (CC) is rising in younger adults and can occur de novo or in patients previously treated for another cancer. To the authors' knowledge, the impact on survival of CC occurring as a subsequent malignant neoplasm (SMN) has not been described for younger patients, which the authors anticipate to be lower with SMNs than that of primary CC. METHODS: Patients aged <50 years with CC in the 2004 through 2014 National Cancer Data Base were identified...
July 10, 2019: Cancer
https://read.qxmd.com/read/31287585/is-cancer-prevention-influenced-by-the-built-environment-a-multidisciplinary-scoping-review
#18
REVIEW
Alexander James David Wray, Leia Michelle Minaker
The built environment is a significant determinant of human health. Globally, the growing prevalence of preventable cancers suggests a need to understand how features of the built environment shape exposure to cancer development and distribution within a population. This scoping review examines how researchers across disparate fields understand and discuss the built environment in primary and secondary cancer prevention. It is focused exclusively on peer-reviewed sources published from research conducted in Australia, Canada, Ireland, New Zealand, the United Kingdom, and the United States from 1990 to 2017...
July 9, 2019: Cancer
https://read.qxmd.com/read/31287570/suicides-and-deaths-linked-to-risky-health-behavior-in-childhood-cancer-patients-a-nordic-population-based-register-study
#19
Liisa M Korhonen, Mervi Taskinen, Matti Rantanen, Friederike Erdmann, Jeanette Falck Winther, Andrea Bautz, Maria Feychting, Hanna Mogensen, Mats Talbäck, Nea Malila, Heidi Ryynänen, Laura Madanat-Harjuoja
BACKGROUND: Childhood cancer survivors have been reported to be vulnerable to psychiatric morbidities and risky health behavior. Suicides, substance abuse, accidents, and violence as causes of death can be regarded as an extreme manifestation of risky health behavior. In the current study, the authors studied the risk of suicide and other risky health behavior-related deaths among childhood cancer patients in Denmark, Finland, and Sweden. METHODS: Using linkage between national cancer, population, and cause-of-death registries, the authors investigated the causes of death in 29,285 patients diagnosed with cancer before age 20 years between 1971 and 2009 compared with a cohort of 146,282 age-matched, sex-matched, and country-matched population comparisons...
July 9, 2019: Cancer
https://read.qxmd.com/read/31287565/providing-health-care-for-patients-with-childhood-cancer-and-survivors-a-survey-of-pediatric-primary-care-providers
#20
Aman Wadhwa, Yanjun Chen, Smita Bhatia, Wendy Landier
BACKGROUND: The current study was conducted to assess self-reported comfort levels of pediatric primary care providers (PCPs) in providing acute medical care to patients with childhood cancer who currently were receiving therapy (on-therapy patients) and health maintenance care to childhood cancer survivors, independently and in conjunction with pediatric oncologists, along with confidence levels regarding knowledge about immunizations for survivors. All levels were measured using 7-point Likert scales...
July 9, 2019: Cancer
journal
journal
20067
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"